Screener/Healthcare/Biotechnology

NTLA

Intellia Therapeutics, Inc.NASDAQ
$12.72-0.39 (-2.97%)
Small CapUnder $20HealthcareFastest GrowingHigh Beta
$5.90
$28.25
$12.63
$13.18
EPS (TTM)$-3.82
P/E Ratio—
Dividend Yield—
Market Cap$1.66B
Volume2.65M
Prev Close$13.11
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$23.0M-$95.8M$-0.82—-416.2%
Q3 '25$13.8M-$101.3M$-0.92—-735.2%
Q2 '25$14.2M-$101.3M$-0.98—-710.8%
Q1 '25$16.6M-$114.3M$-1.10—-687.6%
Q3 '24$9.1M-$135.7M$-1.34—-1489.5%
Q2 '24$7.0M-$147.0M$-1.52—-2112.6%
Q1 '24$28.9M-$107.4M$-1.12—-371.3%
Q4 '23-$1.9M-$132.2M$-1.46—6894.2%
Get Your Daily Market Recap